Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability

Irena Dajic, Ulrich Sauerzopf, Ana Weidenauer, Cornelia Diendorfer, Katharina Landesmann, Ivo Rausch, Andreas Hahn, Benjamin Spurny-Dworak, Manfred Klöbl, Murray Reed, Rupert Lanzenberger, Martin Bauer, Markus Zeitlinger, Lucie Bartova, Martin Wolkersdorfer, Lukas Nics, Wolfgang Wadsak, Marcus Hacker, Cécile Philippe, Nicole Praschak-Rieder, Matthäus Willeit

Open source

DOI: 10.1007/s00259-026-07998-w
Published: 2026-06-15
Container: European Journal of Nuclear Medicine and Molecular Imaging
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00259-026-07998-w,
  title = {Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability},
  author = {Irena Dajic and Ulrich Sauerzopf and Ana Weidenauer and Cornelia Diendorfer and Katharina Landesmann and Ivo Rausch and Andreas Hahn and Benjamin Spurny-Dworak and Manfred Klöbl and Murray Reed and Rupert Lanzenberger and Martin Bauer and Markus Zeitlinger and Lucie Bartova and Martin Wolkersdorfer and Lukas Nics and Wolfgang Wadsak and Marcus Hacker and Cécile Philippe and Nicole Praschak-Rieder and Matthäus Willeit},
  year = {2026},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  doi = {10.1007/s00259-026-07998-w},
  url = {https://doi.org/10.1007/s00259-026-07998-w}
}

RIS

TY  - JOUR
TI  - Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability
AU  - Irena Dajic
AU  - Ulrich Sauerzopf
AU  - Ana Weidenauer
AU  - Cornelia Diendorfer
AU  - Katharina Landesmann
AU  - Ivo Rausch
AU  - Andreas Hahn
AU  - Benjamin Spurny-Dworak
AU  - Manfred Klöbl
AU  - Murray Reed
AU  - Rupert Lanzenberger
AU  - Martin Bauer
AU  - Markus Zeitlinger
AU  - Lucie Bartova
AU  - Martin Wolkersdorfer
AU  - Lukas Nics
AU  - Wolfgang Wadsak
AU  - Marcus Hacker
AU  - Cécile Philippe
AU  - Nicole Praschak-Rieder
AU  - Matthäus Willeit
PY  - 2026
JO  - European Journal of Nuclear Medicine and Molecular Imaging
DO  - 10.1007/s00259-026-07998-w
UR  - https://doi.org/10.1007/s00259-026-07998-w
ER  -

APA

Dajic, I., Sauerzopf, U., Weidenauer, A., Diendorfer, C., Landesmann, K., Rausch, I., Hahn, A., Spurny-Dworak, B., Klöbl, M., Reed, M., Lanzenberger, R., Bauer, M., Zeitlinger, M., Bartova, L., Wolkersdorfer, M., Nics, L., Wadsak, W., Hacker, M., Philippe, C., Praschak-Rieder, N., & Willeit, M. (2026). Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07998-w

Source records

crossref · retrieved 2026-09-25T12:47:12.068Z